SHOULDER INNOVATIONS, INC. Earnings Per Share (Basic)
SHOULDER INNOVATIONS, INC. (SI) reported Earnings Per Share (Basic) of -$0.49 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.49.
- SHOULDER INNOVATIONS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.41.
- SHOULDER INNOVATIONS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.37.
- SHOULDER INNOVATIONS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.64.
- SHOULDER INNOVATIONS, INC. earnings per share, basic for fiscal 2025 was -$4.65.
- SHOULDER INNOVATIONS, INC. earnings per share, basic for fiscal 2024 was -$242.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.49 10-Q · filed 2026-08-06 | -$0.90 10-Q · filed 2026-08-06 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.85 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.41 10-Q · filed 2026-05-13 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.20 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$3.11 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.65 10-K · filed 2026-03-10 |
| 2025-09-30 | -$0.64 10-Q · filed 2025-11-12 | -$4.07 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$7.00 10-Q · filed 2025-11-12 | -$10.47 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$165.53 10-Q · filed 2026-08-06 | -$232.13 10-Q · filed 2026-08-06 | -$286.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$363.59 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$52.13 10-Q · filed 2026-05-13 | -$97.47 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$161.17 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$229.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$45.13 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$109.44 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$179.61 derived: net income ÷ weighted average shares · filed 2026-03-10 | -$242.04 10-K · filed 2026-03-10 |
| 2024-09-30 | -$68.31 10-Q · filed 2025-11-12 | -$140.96 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$203.81 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$72.74 10-Q · filed 2025-09-09 | -$135.51 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |